Immunisation | Control (n=300) | Intervention (n=300) | RR (95% CI) | RD (95% CI) | P value |
Penta-1† n (%) | 289 (97) | 285 (95) | 0.98 (0.95 to 1.02) | −0.02 (−0.05 to 0.015) | 0.31 |
Penta-2† n (%) | 278 (93) | 276 (92) | 0.99 (0.95 to 1.04) | −0.01 (−0.04 to 0.05) | 0.76 |
Penta-3† n (%) | 244 (81) | 257 (86) | 1.05 (0.98 to 1.13) | 0.04 (−0.02 to 0.10) | 0.15 |
Measles‡ n (%) | 196 (66) | 220 (74) | 1.12 (1.01 to 1.25) | 0.08 (0.01 to 0.15) | 0.03 |
*Modified intention-to-treat analysis; includes all subjects regardless of where immunisation was received or how it was audited.
†Assessed at 18 weeks.
‡Assessed at 12 months.
RD, risk difference; RR, risk ratio.